|
5/16/2013 8:00:29 AM
|
|
|
5/16/2013 7:03:08 AM
|
Biostar Pharma Q1 EPS Falls 74% To $0.06 From $0.23 Last Year
|
|
4/15/2013 9:04:13 AM
|
Biostar Pharmaceuticals FY12 Loss Per Share $2.09 Vs. Profit $1.31 Prior Year
|
|
4/15/2013 8:30:41 AM
|
|
|
12/4/2012 7:05:12 AM
|
Biostar Pharma Inks $8 Mln Agreement To Manufacture And Supply Xijing Military Hospital With 16 New Drugs
|
|
11/19/2012 8:30:27 AM
|
|
|
11/19/2012 8:02:49 AM
|
Biostar Pharma Posts Q3 Loss/Share Of $0.63 Vs. Profit $0.47 Last Year
|
|
10/15/2012 7:04:17 AM
|
Biostar Inks 1-year Agreement Valued At $3.0 Mln To Manufacture And Supply Xijing Hospital With Five Addl. Drugs
|
|
10/2/2012 7:07:00 AM
|
Biostar Pharma Inks 1-yr Deal To Manufacture And Supply Xijing Hospital With Three New Drugs
|
|
8/15/2012 9:00:55 AM
|
|
|
8/14/2012 5:25:51 PM
|
Biostar Pharma Posts Q2 Loss/Share Of $1.01 Vs. Profit $0.45 Last Year
|
|
8/3/2012 10:42:23 PM
|
|
|
6/13/2012 7:30:41 AM
|
|
|
6/13/2012 7:03:54 AM
|
Biostar Pharma, FMMU To Jointly Conduct Phases I To III Clinical Trials For Viacom Drug
|
|
4/1/2010 7:46:45 AM
|
Biostar Pharmaceuticals, Inc. (BSPM.OB) Has Raised Its FY10 Revenue Estimate To $80.0 - $82.0 Mln From $69.0 - $71.0 Mln
|